nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP1A1—polycystic ovary syndrome	0.904	1	CbGaD
Granisetron—Migraine—Metformin—polycystic ovary syndrome	0.00186	0.0362	CcSEcCtD
Granisetron—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00175	0.0339	CcSEcCtD
Granisetron—Abdominal distension—Metformin—polycystic ovary syndrome	0.00165	0.032	CcSEcCtD
Granisetron—Angina pectoris—Metformin—polycystic ovary syndrome	0.00159	0.0309	CcSEcCtD
Granisetron—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00138	0.0268	CcSEcCtD
Granisetron—Bradycardia—Metformin—polycystic ovary syndrome	0.00133	0.0259	CcSEcCtD
Granisetron—Rhinitis—Metformin—polycystic ovary syndrome	0.00131	0.0255	CcSEcCtD
Granisetron—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00129	0.025	CcSEcCtD
Granisetron—Flushing—Metformin—polycystic ovary syndrome	0.00122	0.0236	CcSEcCtD
Granisetron—Angiopathy—Metformin—polycystic ovary syndrome	0.00119	0.0231	CcSEcCtD
Granisetron—Chills—Metformin—polycystic ovary syndrome	0.00118	0.0228	CcSEcCtD
Granisetron—Malnutrition—Metformin—polycystic ovary syndrome	0.00114	0.0221	CcSEcCtD
Granisetron—Flatulence—Metformin—polycystic ovary syndrome	0.00112	0.0218	CcSEcCtD
Granisetron—Dysgeusia—Metformin—polycystic ovary syndrome	0.00112	0.0217	CcSEcCtD
Granisetron—Tremor—Metformin—polycystic ovary syndrome	0.00107	0.0207	CcSEcCtD
Granisetron—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00106	0.0205	CcSEcCtD
Granisetron—Malaise—Metformin—polycystic ovary syndrome	0.00103	0.02	CcSEcCtD
Granisetron—Syncope—Metformin—polycystic ovary syndrome	0.00102	0.0199	CcSEcCtD
Granisetron—Palpitations—Metformin—polycystic ovary syndrome	0.00101	0.0196	CcSEcCtD
Granisetron—Loss of consciousness—Metformin—polycystic ovary syndrome	0.001	0.0195	CcSEcCtD
Granisetron—Hypertension—Metformin—polycystic ovary syndrome	0.000985	0.0191	CcSEcCtD
Granisetron—Chest pain—Metformin—polycystic ovary syndrome	0.000971	0.0188	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000964	0.0187	CcSEcCtD
Granisetron—Discomfort—Metformin—polycystic ovary syndrome	0.000959	0.0186	CcSEcCtD
Granisetron—Oedema—Metformin—polycystic ovary syndrome	0.000931	0.0181	CcSEcCtD
Granisetron—Infection—Metformin—polycystic ovary syndrome	0.000925	0.0179	CcSEcCtD
Granisetron—Shock—Metformin—polycystic ovary syndrome	0.000916	0.0178	CcSEcCtD
Granisetron—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000913	0.0177	CcSEcCtD
Granisetron—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000911	0.0177	CcSEcCtD
Granisetron—Skin disorder—Metformin—polycystic ovary syndrome	0.000904	0.0175	CcSEcCtD
Granisetron—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0009	0.0175	CcSEcCtD
Granisetron—Hypotension—Metformin—polycystic ovary syndrome	0.00087	0.0169	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000848	0.0165	CcSEcCtD
Granisetron—Paraesthesia—Metformin—polycystic ovary syndrome	0.000836	0.0162	CcSEcCtD
Granisetron—Dyspnoea—Metformin—polycystic ovary syndrome	0.00083	0.0161	CcSEcCtD
Granisetron—Somnolence—Metformin—polycystic ovary syndrome	0.000827	0.0161	CcSEcCtD
Granisetron—Dyspepsia—Metformin—polycystic ovary syndrome	0.000819	0.0159	CcSEcCtD
Granisetron—Decreased appetite—Metformin—polycystic ovary syndrome	0.000809	0.0157	CcSEcCtD
Granisetron—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000804	0.0156	CcSEcCtD
Granisetron—Constipation—Metformin—polycystic ovary syndrome	0.000796	0.0154	CcSEcCtD
Granisetron—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000767	0.0149	CcSEcCtD
Granisetron—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000761	0.0148	CcSEcCtD
Granisetron—Urticaria—Metformin—polycystic ovary syndrome	0.000739	0.0144	CcSEcCtD
Granisetron—Abdominal pain—Metformin—polycystic ovary syndrome	0.000736	0.0143	CcSEcCtD
Granisetron—Asthenia—Metformin—polycystic ovary syndrome	0.000668	0.013	CcSEcCtD
Granisetron—Pruritus—Metformin—polycystic ovary syndrome	0.000659	0.0128	CcSEcCtD
Granisetron—Diarrhoea—Metformin—polycystic ovary syndrome	0.000637	0.0124	CcSEcCtD
Granisetron—Dizziness—Metformin—polycystic ovary syndrome	0.000616	0.0119	CcSEcCtD
Granisetron—Vomiting—Metformin—polycystic ovary syndrome	0.000592	0.0115	CcSEcCtD
Granisetron—Rash—Metformin—polycystic ovary syndrome	0.000587	0.0114	CcSEcCtD
Granisetron—Dermatitis—Metformin—polycystic ovary syndrome	0.000586	0.0114	CcSEcCtD
Granisetron—Headache—Metformin—polycystic ovary syndrome	0.000583	0.0113	CcSEcCtD
Granisetron—Nausea—Metformin—polycystic ovary syndrome	0.000553	0.0107	CcSEcCtD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000197	0.00449	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SULT2A1—polycystic ovary syndrome	0.000194	0.00442	CbGpPWpGaD
Granisetron—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000193	0.00439	CbGpPWpGaD
Granisetron—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000185	0.00422	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—YAP1—polycystic ovary syndrome	0.000185	0.00422	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—polycystic ovary syndrome	0.000181	0.00413	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00018	0.0041	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000179	0.00408	CbGpPWpGaD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000177	0.00403	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000174	0.00396	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00017	0.00388	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000162	0.00369	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000158	0.0036	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000157	0.00358	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000156	0.00355	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000149	0.00339	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000147	0.00334	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000145	0.00331	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000145	0.0033	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00014	0.0032	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00014	0.00318	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000139	0.00316	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000139	0.00316	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000137	0.00312	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—polycystic ovary syndrome	0.000134	0.00305	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000134	0.00304	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000132	0.003	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000132	0.003	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000131	0.00297	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00013	0.00296	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00013	0.00295	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000129	0.00293	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000128	0.00292	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000128	0.00292	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000128	0.00291	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000127	0.0029	CbGpPWpGaD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000126	0.00287	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000126	0.00286	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—polycystic ovary syndrome	0.000125	0.00284	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000125	0.00284	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000123	0.0028	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000121	0.00276	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000121	0.00276	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000121	0.00275	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000119	0.00272	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000119	0.0027	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000114	0.00261	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000114	0.0026	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000114	0.00259	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000113	0.00257	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000112	0.00255	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	0.00011	0.0025	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000108	0.00247	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.000108	0.00245	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000106	0.00241	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000104	0.00238	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000104	0.00237	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000104	0.00237	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000103	0.00235	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000103	0.00235	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.00235	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000103	0.00235	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000102	0.00233	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000102	0.00232	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.96e-05	0.00227	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	9.92e-05	0.00226	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	9.81e-05	0.00223	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	9.57e-05	0.00218	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	9.5e-05	0.00216	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	9.44e-05	0.00215	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	9.25e-05	0.00211	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	9.12e-05	0.00208	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	9.04e-05	0.00206	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	8.92e-05	0.00203	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	8.72e-05	0.00199	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	8.63e-05	0.00196	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	8.61e-05	0.00196	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	8.6e-05	0.00196	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	8.48e-05	0.00193	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.38e-05	0.00191	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.33e-05	0.0019	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	8.27e-05	0.00188	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.22e-05	0.00187	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	7.89e-05	0.0018	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARG—polycystic ovary syndrome	7.88e-05	0.00179	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	7.71e-05	0.00176	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	7.71e-05	0.00176	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.7e-05	0.00175	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	7.61e-05	0.00173	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	7.41e-05	0.00169	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.32e-05	0.00167	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	6.83e-05	0.00155	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.8e-05	0.00155	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	6.79e-05	0.00155	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	6.75e-05	0.00154	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	6.73e-05	0.00153	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.71e-05	0.00153	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	6.71e-05	0.00153	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NMNAT3—polycystic ovary syndrome	6.41e-05	0.00146	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.21e-05	0.00141	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	6.21e-05	0.00141	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	6.21e-05	0.00141	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	6.12e-05	0.00139	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	6.05e-05	0.00138	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	5.98e-05	0.00136	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.96e-05	0.00136	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—LPCAT2—polycystic ovary syndrome	5.86e-05	0.00134	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SUOX—polycystic ovary syndrome	5.86e-05	0.00134	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	5.79e-05	0.00132	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	5.77e-05	0.00131	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	5.75e-05	0.00131	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.63e-05	0.00128	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.62e-05	0.00128	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.54e-05	0.00126	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.49e-05	0.00125	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ISYNA1—polycystic ovary syndrome	5.45e-05	0.00124	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—POMC—polycystic ovary syndrome	5.43e-05	0.00124	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.41e-05	0.00123	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	5.33e-05	0.00121	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	5.31e-05	0.00121	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.03e-05	0.00115	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	4.97e-05	0.00113	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	4.91e-05	0.00112	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	4.91e-05	0.00112	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	4.82e-05	0.0011	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	4.72e-05	0.00107	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	4.63e-05	0.00106	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	4.63e-05	0.00106	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	4.46e-05	0.00101	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.45e-05	0.00101	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	4.41e-05	0.001	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	4.41e-05	0.001	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.39e-05	0.000999	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	4.39e-05	0.000999	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	4.11e-05	0.000936	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	4.1e-05	0.000934	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	4.09e-05	0.000931	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	3.9e-05	0.000887	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	3.88e-05	0.000884	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	3.72e-05	0.000847	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	3.68e-05	0.000838	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.59e-05	0.000817	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.54e-05	0.000805	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	3.51e-05	0.0008	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.49e-05	0.000794	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.49e-05	0.000794	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.47e-05	0.000791	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	3.31e-05	0.000755	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	3.16e-05	0.00072	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.15e-05	0.000718	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	3.13e-05	0.000713	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.99e-05	0.00068	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.95e-05	0.000672	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.92e-05	0.000666	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.89e-05	0.000657	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.89e-05	0.000657	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	2.88e-05	0.000656	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	2.82e-05	0.000642	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.77e-05	0.000631	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	2.73e-05	0.000621	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	2.72e-05	0.00062	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.68e-05	0.000611	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.67e-05	0.000609	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.66e-05	0.000606	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.64e-05	0.000602	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.58e-05	0.000587	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	2.51e-05	0.000572	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	2.43e-05	0.000554	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.37e-05	0.00054	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.36e-05	0.000537	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	2.34e-05	0.000534	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	2.3e-05	0.000523	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.28e-05	0.000519	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.28e-05	0.000519	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	2.25e-05	0.000513	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	2.25e-05	0.000512	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	2.22e-05	0.000507	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	2.21e-05	0.000504	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	2.13e-05	0.000485	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.12e-05	0.000482	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.1e-05	0.000479	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	2.1e-05	0.000478	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.09e-05	0.000475	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	2.07e-05	0.000471	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	2.05e-05	0.000467	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2e-05	0.000456	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.98e-05	0.000452	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.95e-05	0.000445	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.94e-05	0.000442	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.91e-05	0.000435	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.81e-05	0.000413	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.79e-05	0.000407	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.79e-05	0.000407	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.74e-05	0.000396	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.73e-05	0.000394	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.73e-05	0.000394	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.69e-05	0.000385	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.67e-05	0.00038	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.64e-05	0.000374	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	1.64e-05	0.000373	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.6e-05	0.000365	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.58e-05	0.00036	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.55e-05	0.000352	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.54e-05	0.000351	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.49e-05	0.00034	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.47e-05	0.000335	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.47e-05	0.000335	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	1.46e-05	0.000333	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.39e-05	0.000317	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	1.38e-05	0.000314	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.34e-05	0.000305	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.32e-05	0.0003	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	1.31e-05	0.000299	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.31e-05	0.000298	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.27e-05	0.00029	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.27e-05	0.000289	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.24e-05	0.000282	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.23e-05	0.00028	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.17e-05	0.000266	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.16e-05	0.000265	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.16e-05	0.000265	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.13e-05	0.000257	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.09e-05	0.000248	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.05e-05	0.000238	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.04e-05	0.000237	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.03e-05	0.000235	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	9.97e-06	0.000227	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	9.9e-06	0.000225	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	9.84e-06	0.000224	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—INS—polycystic ovary syndrome	9.78e-06	0.000223	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.77e-06	0.000222	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.61e-06	0.000219	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	9.42e-06	0.000215	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	9.38e-06	0.000214	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	9.29e-06	0.000212	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—INS—polycystic ovary syndrome	9.24e-06	0.00021	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	8.74e-06	0.000199	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.32e-06	0.000189	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.09e-06	0.000184	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.61e-06	0.000173	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	7.09e-06	0.000161	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.99e-06	0.000159	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.96e-06	0.000158	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.79e-06	0.000155	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.47e-06	0.000147	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.13e-06	0.00014	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.72e-06	0.00013	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.64e-06	0.000106	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.57e-06	0.000104	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.55e-06	0.000104	CbGpPWpGaD
